Cotinga Pharmaceuticals, Inc. is a clinical stage biotechnology company. It engages in the business of utilizing proprietary artificial intelligence technologies to pursue a targeted and transformational approach in treating cancer and other unmet medical needs. The company was founded on October 13, 2006 and is headquartered in Boston, MA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company